Skip to main content
Erschienen in: European Journal of Nutrition 7/2012

01.10.2012 | Original Contribution

Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance

verfasst von: Renee E. Stubbins, Valerie B. Holcomb, Jina Hong, Nomelí P. Núñez

Erschienen in: European Journal of Nutrition | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Obesity increases the risk of diabetes. The dysregulation of estrogen metabolism has been associated with the susceptibility to obesity and diabetes. Here, we explore the role estrogen plays in sex differences in obesity and glucose metabolism, specifically adipocyte biology.

Methods

We randomized C57BL/6 J male, non-ovariectomized female, ovariectomized female, and ovariectomized female mice supplemented with 17β estradiol to receive a calorie-restricted, low- or a high-fat diet (15 mice per group). We measured weight gained, calories consumed, percent body fat, abdominal adipose tissue, adipocyte size, lipogenic and adipogenic gene expression, and glucose tolerance.

Results

Male mice had a higher susceptibility to obesity than intact female mice. However, removal of the ovaries in female mice eliminated the protection to obesity and estrogen supplementation restored this protection. Male and ovariectomized female mice gained weight predominately in the form of abdominal adipose tissue possibly due to an increase in adipocyte size. Moreover, for mice consuming the high-fat diet, male and ovariectomized female mice had significantly higher levels of leptin mRNA and lower hormone-sensitive lipase mRNA relative to intact female mice and ovariectomized female mice supplemented with estrogen. Additionally, estrogen had a strong inhibitory effect on key adipogenic genes in non-ovariectomized female and ovx-female mice supplemented with estrogen. Finally, we show that male and ovariectomized female mice consuming the high-fat diet had a higher incidence of glucose intolerance.

Conclusion

Estrogen protects female mice from obesity and impaired glucose tolerance possibly by modulating the expression of genes regulating adipogenesis, lipogenesis, and lipolysis.
Literatur
1.
Zurück zum Zitat Flegal K, Carroll M, Ogden C, Johnson C (2002) Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288:1723–1727CrossRef Flegal K, Carroll M, Ogden C, Johnson C (2002) Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288:1723–1727CrossRef
2.
Zurück zum Zitat Hong J, Stubbins R, Smith R, Harvey A, Núñez N (2009) Differential susceptibility to obesity between male, female and ovariectomized female mice. Nutr J 8:11–16CrossRef Hong J, Stubbins R, Smith R, Harvey A, Núñez N (2009) Differential susceptibility to obesity between male, female and ovariectomized female mice. Nutr J 8:11–16CrossRef
3.
Zurück zum Zitat Cooke PS, Naaz A (2004) Role of estrogens in adipocyte development and function. Exp Biol Med (Maywood) 229:1127–1135 Cooke PS, Naaz A (2004) Role of estrogens in adipocyte development and function. Exp Biol Med (Maywood) 229:1127–1135
4.
Zurück zum Zitat Wade GN, Gray JM, Bartness TJ (1985) Gonadal influences on adiposity. Int J Obes 9 Suppl 1:83–92 Wade GN, Gray JM, Bartness TJ (1985) Gonadal influences on adiposity. Int J Obes 9 Suppl 1:83–92
5.
Zurück zum Zitat Meli R, Pacilio M, Raso GM, Esposito E, Coppola A, Nasti A, Di Carlo C, Nappi C, Di Carlo R (2004) Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 145:3115–3121CrossRef Meli R, Pacilio M, Raso GM, Esposito E, Coppola A, Nasti A, Di Carlo C, Nappi C, Di Carlo R (2004) Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 145:3115–3121CrossRef
6.
Zurück zum Zitat Jones M, Thorburn A, Britt K, Hewitt K, Wreford N, Proietto J, Oz O, Leury B, Robertson K, Yao S, Simpson E (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97:12735–12740CrossRef Jones M, Thorburn A, Britt K, Hewitt K, Wreford N, Proietto J, Oz O, Leury B, Robertson K, Yao S, Simpson E (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97:12735–12740CrossRef
7.
Zurück zum Zitat Hao L, Wang Y, Duan Y, Bu S (2010) Effects of treadmill exercise training on liver fat accumulation and estrogen receptor alpha expression in intact and ovariectomized rats with or without estrogen replacement treatment. Eur J Appl Physiol 109:879–886CrossRef Hao L, Wang Y, Duan Y, Bu S (2010) Effects of treadmill exercise training on liver fat accumulation and estrogen receptor alpha expression in intact and ovariectomized rats with or without estrogen replacement treatment. Eur J Appl Physiol 109:879–886CrossRef
8.
Zurück zum Zitat Heine P, Taylor J, Iwamoto G, Lubahn D, Cooke P (2000) Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 97:12729–12734CrossRef Heine P, Taylor J, Iwamoto G, Lubahn D, Cooke P (2000) Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 97:12729–12734CrossRef
9.
Zurück zum Zitat Brown LM, Clegg DJ (2010) Central effects of estradiol in the regulation of food intake, body weight, and adiposity. J Steroid Biochem Mol Biol 122:65–73CrossRef Brown LM, Clegg DJ (2010) Central effects of estradiol in the regulation of food intake, body weight, and adiposity. J Steroid Biochem Mol Biol 122:65–73CrossRef
10.
Zurück zum Zitat Eckel LA (2011) The ovarian hormone estradiol plays a crucial role in the control of food intake in females. Physiol Behav 104:517–524CrossRef Eckel LA (2011) The ovarian hormone estradiol plays a crucial role in the control of food intake in females. Physiol Behav 104:517–524CrossRef
11.
Zurück zum Zitat Musatov S, Chen W, Pfaff D, Mobbs C, Yang X, Clegg D, Kaplitt M, Ogawa S (2007) Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci USA 104:2501–2506CrossRef Musatov S, Chen W, Pfaff D, Mobbs C, Yang X, Clegg D, Kaplitt M, Ogawa S (2007) Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci USA 104:2501–2506CrossRef
12.
Zurück zum Zitat Homma H, Kurachi H, Nishio Y, Takeda T, Yamamoto T, Adachi K, Morishige K, Ohmichi M, Matsuzawa Y, Murata Y (2000) Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. J Biol Chem 275:11404–11411CrossRef Homma H, Kurachi H, Nishio Y, Takeda T, Yamamoto T, Adachi K, Morishige K, Ohmichi M, Matsuzawa Y, Murata Y (2000) Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. J Biol Chem 275:11404–11411CrossRef
13.
Zurück zum Zitat D’Eon T, Souza S, Aronovitz M, Obin M, Fried S, Greenberg A (2005) Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 280:35983–35991CrossRef D’Eon T, Souza S, Aronovitz M, Obin M, Fried S, Greenberg A (2005) Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 280:35983–35991CrossRef
14.
Zurück zum Zitat Wu Z, Xie Y, Bucher NL, Farmer SR (1995) Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev 9:2350–2363CrossRef Wu Z, Xie Y, Bucher NL, Farmer SR (1995) Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev 9:2350–2363CrossRef
15.
Zurück zum Zitat Phan J, Peterfy M, Reue K (2005) Biphasic expression of lipin suggests dual roles in adipocyte development. Drug News Perspect 18:5–11CrossRef Phan J, Peterfy M, Reue K (2005) Biphasic expression of lipin suggests dual roles in adipocyte development. Drug News Perspect 18:5–11CrossRef
16.
Zurück zum Zitat Tontonoz P, Hu E, Spiegelman BM (1994) Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79:1147–1156CrossRef Tontonoz P, Hu E, Spiegelman BM (1994) Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79:1147–1156CrossRef
17.
Zurück zum Zitat Yakar S, Nunez N, Pennisi P, Brodt P, Sun H, Fallavollita L, Zhao H, Scavo L, Novosyadlyy R, Kurshan N, Stannard B, East-Palmer J, Smith N, Perkins S, Fuchs-Young R, Barrett J, Hursting S, LeRoith D (2006) Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. Endocrinology 147:5826–5834CrossRef Yakar S, Nunez N, Pennisi P, Brodt P, Sun H, Fallavollita L, Zhao H, Scavo L, Novosyadlyy R, Kurshan N, Stannard B, East-Palmer J, Smith N, Perkins S, Fuchs-Young R, Barrett J, Hursting S, LeRoith D (2006) Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. Endocrinology 147:5826–5834CrossRef
18.
Zurück zum Zitat Giovannucci E, Ascherio A, Rimm E, Colditz G, Stampfer M, Willett W (1995) Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 122:327–334 Giovannucci E, Ascherio A, Rimm E, Colditz G, Stampfer M, Willett W (1995) Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 122:327–334
19.
Zurück zum Zitat Macotela Y, Boucher J, Tran TT, Kahn CR (2009) Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes 58:803–812CrossRef Macotela Y, Boucher J, Tran TT, Kahn CR (2009) Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes 58:803–812CrossRef
20.
Zurück zum Zitat Núñez N, Carpenter C, Perkins S, Berrigan D, Jaque S, Ingles S, Bernstein L, Forman M, Barrett J, Hursting S (2007) Extreme obesity reduces bone mineral density: complementary evidence from mice and women. Obesity (Silver Spring) 15:1980–1987CrossRef Núñez N, Carpenter C, Perkins S, Berrigan D, Jaque S, Ingles S, Bernstein L, Forman M, Barrett J, Hursting S (2007) Extreme obesity reduces bone mineral density: complementary evidence from mice and women. Obesity (Silver Spring) 15:1980–1987CrossRef
21.
Zurück zum Zitat Karas RH, Schulten H, Pare G, Aronovitz MJ, Ohlsson C, Gustafsson JA, Mendelsohn ME (2001) Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice. Circ Res 89:534–539CrossRef Karas RH, Schulten H, Pare G, Aronovitz MJ, Ohlsson C, Gustafsson JA, Mendelsohn ME (2001) Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice. Circ Res 89:534–539CrossRef
22.
Zurück zum Zitat Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner A, Cushman S, Periwal V (2009) Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth. PLoS Comput Biol 5:e1000324CrossRef Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner A, Cushman S, Periwal V (2009) Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth. PLoS Comput Biol 5:e1000324CrossRef
23.
Zurück zum Zitat Hinz S, Rais-Bahrami S, Kempkensteffen C, Weiske W, Miller K, Magheli A (2010) Effect of obesity on sex hormone levels, antisperm antibodies, and fertility after vasectomy reversal. Urology 76:851–856CrossRef Hinz S, Rais-Bahrami S, Kempkensteffen C, Weiske W, Miller K, Magheli A (2010) Effect of obesity on sex hormone levels, antisperm antibodies, and fertility after vasectomy reversal. Urology 76:851–856CrossRef
24.
Zurück zum Zitat Oh J, Barrett-Connor E, Wedick N, Wingard D, Study RB (2002) Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 25:55–60CrossRef Oh J, Barrett-Connor E, Wedick N, Wingard D, Study RB (2002) Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 25:55–60CrossRef
25.
Zurück zum Zitat de Ferranti S, Mozaffarian D (2008) The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 54:945–955CrossRef de Ferranti S, Mozaffarian D (2008) The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 54:945–955CrossRef
26.
Zurück zum Zitat Imbeault P, Lemieux S, Prud’homme D, Tremblay A, Nadeau A, Després J, Mauriège P (1999) Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy? Metabolism 48:355–362CrossRef Imbeault P, Lemieux S, Prud’homme D, Tremblay A, Nadeau A, Després J, Mauriège P (1999) Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy? Metabolism 48:355–362CrossRef
27.
Zurück zum Zitat Roberts R, Hodson L, Dennis A, Neville M, Humphreys S, Harnden K, Micklem K, Frayn K (2009) Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia 52:882–890CrossRef Roberts R, Hodson L, Dennis A, Neville M, Humphreys S, Harnden K, Micklem K, Frayn K (2009) Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia 52:882–890CrossRef
28.
Zurück zum Zitat Fenton J, Nuñez N, Yakar S, Perkins S, Hord N, Hursting SD (2009) Diet-induced adiposity alters the serum profile of inflammation in C57BL/6 N mice as measured by antibody array. Diabetes Obes Metab 11:343–354CrossRef Fenton J, Nuñez N, Yakar S, Perkins S, Hord N, Hursting SD (2009) Diet-induced adiposity alters the serum profile of inflammation in C57BL/6 N mice as measured by antibody array. Diabetes Obes Metab 11:343–354CrossRef
29.
Zurück zum Zitat Frederich R, Hamann A, Anderson S, Löllmann B, Lowell B, Flier J (1995) Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311–1314CrossRef Frederich R, Hamann A, Anderson S, Löllmann B, Lowell B, Flier J (1995) Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311–1314CrossRef
30.
Zurück zum Zitat Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, Prabhala A, Afzal A, Garg R (2001) The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 86:355–362CrossRef Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, Prabhala A, Afzal A, Garg R (2001) The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 86:355–362CrossRef
31.
Zurück zum Zitat Lundholm L, Zang H, Hirschberg A, Gustafsson J, Arner P, Dahlman-Wright K (2008) Key lipogenic gene expression can be decreased by estrogen in human adipose tissue. Fertil Steril 90:44–48CrossRef Lundholm L, Zang H, Hirschberg A, Gustafsson J, Arner P, Dahlman-Wright K (2008) Key lipogenic gene expression can be decreased by estrogen in human adipose tissue. Fertil Steril 90:44–48CrossRef
32.
Zurück zum Zitat Hewitt K, Pratis K, Jones M, Simpson E (2004) Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology 145:1842–1848CrossRef Hewitt K, Pratis K, Jones M, Simpson E (2004) Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology 145:1842–1848CrossRef
33.
Zurück zum Zitat Abraham S, Hillyard L, Hansen F, Lin C (1980) Tissue specificity for the effect of estrogen on lipogenic activity in male and female rats. Biochim Biophys Acta 620:167–171CrossRef Abraham S, Hillyard L, Hansen F, Lin C (1980) Tissue specificity for the effect of estrogen on lipogenic activity in male and female rats. Biochim Biophys Acta 620:167–171CrossRef
34.
Zurück zum Zitat Hu E, Tontonoz P, Spiegelman BM (1995) Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci USA 92:9856–9860CrossRef Hu E, Tontonoz P, Spiegelman BM (1995) Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci USA 92:9856–9860CrossRef
35.
Zurück zum Zitat Koh YK, Lee MY, Kim JW, Kim M, Moon JS, Lee YJ, Ahn YH, Kim KS (2008) Lipin1 is a key factor for the maturation and maintenance of adipocytes in the regulatory network with CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma 2. J Biol Chem 283:34896–34906CrossRef Koh YK, Lee MY, Kim JW, Kim M, Moon JS, Lee YJ, Ahn YH, Kim KS (2008) Lipin1 is a key factor for the maturation and maintenance of adipocytes in the regulatory network with CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma 2. J Biol Chem 283:34896–34906CrossRef
36.
Zurück zum Zitat Yepuru M, Eswaraka J, Kearbey J, Barrett C, Raghow S, Veverka K, Miller D, Dalton J, Narayanan R (2010) Estrogen receptor-{beta} selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice. J Biol Chem 285:31292–31303CrossRef Yepuru M, Eswaraka J, Kearbey J, Barrett C, Raghow S, Veverka K, Miller D, Dalton J, Narayanan R (2010) Estrogen receptor-{beta} selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice. J Biol Chem 285:31292–31303CrossRef
37.
Zurück zum Zitat Campbell SE, Mehan KA, Tunstall RJ, Febbraio MA, Cameron-Smith D (2003) 17beta-estradiol upregulates the expression of peroxisome proliferator-activated receptor alpha and lipid oxidative genes in skeletal muscle. J Mol Endocrinol 31:37–45CrossRef Campbell SE, Mehan KA, Tunstall RJ, Febbraio MA, Cameron-Smith D (2003) 17beta-estradiol upregulates the expression of peroxisome proliferator-activated receptor alpha and lipid oxidative genes in skeletal muscle. J Mol Endocrinol 31:37–45CrossRef
38.
Zurück zum Zitat Campbell S, Febbraio M (2001) Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway of skeletal muscle. Am J Physiol Endocrinol Metab 281:E803–E808 Campbell S, Febbraio M (2001) Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway of skeletal muscle. Am J Physiol Endocrinol Metab 281:E803–E808
39.
Zurück zum Zitat Morise A, Thomas C, Landrier J, Besnard P, Hermier D (2009) Hepatic lipid metabolism response to dietary fatty acids is differently modulated by PPARalpha in male and female mice. Eur J Nutr 48:465–473CrossRef Morise A, Thomas C, Landrier J, Besnard P, Hermier D (2009) Hepatic lipid metabolism response to dietary fatty acids is differently modulated by PPARalpha in male and female mice. Eur J Nutr 48:465–473CrossRef
Metadaten
Titel
Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance
verfasst von
Renee E. Stubbins
Valerie B. Holcomb
Jina Hong
Nomelí P. Núñez
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Nutrition / Ausgabe 7/2012
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-011-0266-4

Weitere Artikel der Ausgabe 7/2012

European Journal of Nutrition 7/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.